LRRC8A and pancreatic adenocarcinoma: Additionally, qRT-PCR and western blot results showed LRRC8A decreased after AsPC-1GEMR cells were pretreated with DCPIB (Supplementary Figure S1d) and the knockdown effect of shLRRC8A in PAAD cell lines was showed in Supplementary Figure S1e.